Biblio Discovery — Demo Discovery Service

8 hasil untuk "Simon R Procter"

Menampilkan 1–8 · 0,20 detik · RSS

  1. Artikel Jurnal Teks lengkap

    paramix : An R package for parameter discretisation in compartmental models, with application to calculating years of life lost

    Lucy Goodfellow; Carl A. B. Pearson; Simon R. Procter

    PLOS Computational Biology, Vol. 21 No. 9 · 2025 · Inggris · PLOS Scopus

    Compartmental infectious disease models are used to calculate disease transmission, estimate underlying rates, forecast future burden, and compare benefits across intervention scenarios. These models aggregate individuals into compartments, often stratified by characteristics to represent groups…

  2. Artikel Jurnal Teks lengkap

    Estimation of country-level incidence of early-onset invasive Group B Streptococcus disease in infants using Bayesian methods

    Bronner P. Gonçalves; Simon R. Procter; Sam Clifford dkk.

    PLOS Computational Biology, Vol. 17 No. 6 · 2021 · Inggris · PLOS Scopus

    Neonatal invasive disease caused by Group B Streptococcus (GBS) is responsible for much acute mortality and long-term morbidity. To guide development of better prevention strategies, including maternal vaccines that protect neonates against GBS, it is necessary to estimate the burden of this…

  3. Artikel Jurnal Teks lengkap

    The benefits and risks of maternal RSV vaccination on mortality in South Africa: A modeling study

    Ayaka Monoi; Akira Endo; Simon R. Procter dkk.

    PLOS Medicine, Vol. 23 No. 1 · 2026 · Inggris · PLOS Scopus

    Background: Maternal respiratory syncytial virus (RSV) vaccine, RSV prefusion F protein vaccine (RSVpreF (Abrysvo)), was found to be safe and efficacious in the MATISSE trial. However, post-hoc stratified analyses identified an excess of preterm births in the intervention arm in two…

  4. Artikel Jurnal Teks lengkap

    Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness

    Simon R. Procter; Bronner P. Gonçalves; Proma Paul dkk.

    PLOS Medicine, Vol. 20 No. 3 · 2023 · Inggris · PLOS Scopus

    …at reasonable prices is likely to be a cost-effective intervention. Simon R Procter and colleagues explore the global health impact and cost-effectiveness of maternal immunisation against Group B Streptococcus. Why was this study done?: What did the researchers do and find?: What do these findings…

  5. Artikel Jurnal Teks lengkap

    What, how and who: Cost-effectiveness analyses of COVID-19 vaccination to inform key policies in Nigeria

    Francis J. Ruiz; Sergio Torres-Rueda; Carl A. B. Pearson dkk.

    PLOS Global Public Health, Vol. 3 No. 3 · 2023 · Inggris · PLOS Scopus

    While safe and efficacious COVID-19 vaccines have achieved high coverage in high-income settings, roll-out remains slow in sub-Saharan Africa. By April 2022, Nigeria, a country of over 200 million people, had only distributed 34 million doses. To ensure the optimal use of health resources…

  6. Artikel Jurnal Teks lengkap

    COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness

    Carl A. B. Pearson; Fiammetta Bozzani; Simon R. Procter dkk.

    PLOS Medicine, Vol. 18 No. 10 · 2021 · Inggris · PLOS Scopus

    Background: Multiple Coronavirus Disease 2019 (COVID-19) vaccines appear to be safe and efficacious, but only high-income countries have the resources to procure sufficient vaccine doses for most of their eligible populations. The World Health Organization has published guidelines for vaccine…

  7. Artikel Jurnal Teks lengkap

    The potential global health impact and cost-effectiveness of next-generation influenza vaccines: A modelling analysis

    Lucy Goodfellow; Simon R Procter; Mihaly Koltai dkk.

    PLOS Medicine, Vol. 22 No. 6 · 2025 · Inggris · PLOS Scopus

    Background: Next-generation influenza vaccines (NGIVs) are in development and have the potential to achieve substantial reductions in influenza burden, with resulting widespread health and economic benefits. The prices at which their market can be sustained and which vaccination strategies may…